Xpovio combined with Incyte’s Jakafi helped on one key measure but missed on other goal in a disorder that, by one analyst’s ...
Multiple myeloma care shifts to four-drug frontline regimens and MRD testing, boosting deep responses and guiding relapse strategies like BCMA CAR-T and genomic profiling. Dr. Nooka traces the 15-year ...
The FDA approved a steroid-sparing Tecvayli and Darzalex Faspro combo for relapsed myeloma, offering an 83% reduction in disease progression risk.
Explore the latest advancements in bispecific antibodies for multiple myeloma, focusing on early treatment opportunities and innovative trial designs. In this episode, experts discuss the reemergence ...
Add Yahoo as a preferred source to see more of our stories on Google. A micrograph of myeloma neoplasm in a bone marrow biopsy. Johnson & Johnson’s Tecvayli helped people with multiple myeloma live ...
"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...
Commonly prescribed heart medications, including statins and diuretics, do not negatively affect the survival of patients with multiple myeloma. SHARJAH, EMIRATE OF ...
IASO Biotechnology ("IASO Bio"), a commercial-stage biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of novel cell therapies and biologics for ...
Anemia often goes hand-in-hand with multiple myeloma. Sometimes, the cancer causes the anemia. And sometimes, the cancer treatment does. But it's possible to resolve it and feel better. (Photo Credit: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results